Skip to Content
  • Previous Rank15
  • Revenues ($M)138,030
  • Revenue Percent Change12.7%
  • Profits ($M)1,263
  • Profits Percent Change-5.6%
  • Market Value (as of March 31, 2015)52,669

McKesson, the largest U.S. pharmaceutical distributor, has been on a roll in 2015 thanks to rising sales in its wholesale drug distribution segment and its increased stake in Germany’s Celesio. McKesson first acquired 50.1% of the Germany-based company in October 2013, giving the distributor a bigger hand in the global generic-drug market. The San Francisco-based firm finally acquired the full company at the beginning of last year and has been busy integrating the new purchase. In addition to its health care distribution business, McKesson also develops, implements and supports software within the medical community, which is often underappreciated relative to the company’s larger distribution unit. Its technology solutions segment is on pace to bring in more than $3 billion in 2015, making it the industry’s No. 2 leader to Cerner. McKesson offers IT services such as electronic health records systems, health-plan payment management and revenue cycle management.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
John H. Hammergren
Industry
Wholesalers: Health Care
Sector
Wholesalers
HQ Location
San Francisco, CA
Websitehttp://www.mckesson.com
Years on List21

Key Financials (last fiscal year)

$ millions% change
Revenues ($M)138,03012.7%
Profits ($M)1,263-5.6%
Total Stockholder Equity8,522-
Employees42,800-
Market Value (as of March 31, 2015)52,669-

Profit Ratios

Profit as % of Revenues0.9%
Profits as % of Assets2.4%
Profits as % of Stockholder Equity14.8%

Earnings Per Share (last fiscal year)

Earnings Per Share ($)5.41
EPS % Change (from 2013)-3.2%
EPS % Change (5 year annual rate)12.9%
EPS % Change (10 year annual rate)9.5%

Total Return

Total Return to Investors (2014)29.3%
Total Return to Investors (5 year, annualized)28.2%
Total Return to Investors (10 year, annualized)21.7%